Damage-resistant DNA synthesis in fanconi anemia cells treated with a DNA cross-linking agent

Experimental Cell Research

Volumn 260, Issue 2, 2000, Pages 216-221

  Centurion, Santiago A ^a   Kuo, Hon Reen ^a   Lambert, W Clark ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cell cycle; DNA cross links; DNA damage; DNA synthesis; Fanconi anemia; Psoralen

Indexed keywords

MESYLIC ACID METHYL ESTER; METHOXSALEN;

ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DNA CROSS LINKING; DNA DAMAGE; DNA REPLICATION; DNA SYNTHESIS; FANCONI ANEMIA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0034332550     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4995     Document Type: Article

References (34)

1. Fanconi's anemia and malignancies
2. 2 prophase
3. 2 phase
4. Modulation of the spontaneous G2 phase blockage in Fanconi anemia cells by caffeine: Differences from cells arrested by X-irradiation
5. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia
6. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents
7. Molecular biology of Fanconi anemia: Implications for diagnosis and therapy
8. 2 checkpoint regulation
9. 2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function
10. Evidence for at least eight Fanconi anemia genes
11. Cloning of cDNAs for Fanconi anemia by functional complementation
12. Expression cloning of a cDNA for the major Fanconi anemia gene
13. Fanconi anemia/breast cancer consortium. Positional cloning of the Fanconi anemia group A gene
14. The Fanconi anemia group G gene FANCG is identical with XRCC9
15. Microcell mediated chromosome transfer maps the Fanconi anemia group D gene to chromosome 3p
16. Expression of the Fanconi anemia group C gene in hematopoietic cells is not influenced by oxidative stress, cross-linking agents, radiation, heat, or mitotic inhibitory factors
17. Human α spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex
18. 2 delay and spontaneous chromosomal aberrations in ataxia-telangiectasia homozygotes and heterozygotes
19. Retroviral gene transfer for the assignment of Fanconi anemia (FA) proteins to a FA complementation group
20. Identification of early apoptosis in Feulgen-stained cultured cells in situ by computerized image analysis
21. Correction of the DNA repair defect in Fanconi anemia, complementation groups A and D, cells
22. DNA photobinding of 7-methylpyrido-(3,4,5)psoralen and 8-methoxypsoralen: Effects of macromolecular synthesis, repair and survival in cultured human cells
23. Immunological probing of induction and repair of 8-methoxypsoralen photoadducts in DNA from Fanconi anemia and normal human fibroblasts: Quantitative analysis by electron microscopy
24. The reaction of the psoralens with deoxyribonucleic acid
25. Genotoxic potential of psoralen crosslinks versus monoadducts in normal human lymphoblasts
26. In vivo formation and persistence of modified nucleosides resulting from alkylating agents
27. Correction of the ultraviolet induced DNA repair defect in xeroderma pigmentosum cells by electroporation of a normal human endonuclease
28. Effects of mitomycin C on the rate of DNA synthesis in normal and Fanconi anemia cells
29. Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene
30. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase
31. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2
32. The p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia
33. Mutagenic activity of ambient oxygen and mitomycin C in Fanconi's anemia cells
34. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines